Picture of Oncolytics Biotech logo

ONCY — Oncolytics Biotech News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Brief: Oncolytics Biotech says Reolysin doubles survival in breast cancer patients

April 5 (Reuters) - Oncolytics Biotech Inc  ONC.TO  
    * Oncolytics Biotech inc says Reolysin more than doubles 
overall survival in patients with mutated p53 metastatic breast 
cancer 
    * Oncolytics Biotech -patients with mutated p53 metastatic 
breast cancer saw a statistically significant improvement in 
median overall survival 
 
Source text for Eikon:  ID:nPn3qW6BVa  
Further company coverage:  ONC.TO  
 
 ((Bangalore.newsroom@thomsonreuters.com;))

Recent news on Oncolytics Biotech

See all news